Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 25.33B | 22.68B | 23.23B | 21.07B | 17.87B |
Gross Profit | 9.79B | 8.74B | 8.77B | 7.92B | 7.04B |
EBITDA | 5.54B | 4.43B | 5.40B | 4.54B | 3.67B |
Net Income | 3.11B | 2.15B | 3.16B | 2.70B | 1.93B |
Balance Sheet | |||||
Total Assets | 31.20B | 28.25B | 25.99B | 23.72B | 19.88B |
Cash, Cash Equivalents and Short-Term Investments | 12.14B | 10.56B | 8.70B | 5.57B | 5.26B |
Total Debt | 2.79B | 3.05B | 3.13B | 3.80B | 4.05B |
Total Liabilities | 7.97B | 6.86B | 7.05B | 8.13B | 8.13B |
Stockholders Equity | 23.22B | 21.40B | 18.94B | 15.59B | 11.76B |
Cash Flow | |||||
Free Cash Flow | 3.55B | 2.97B | 3.82B | 624.11M | 1.27B |
Operating Cash Flow | 5.19B | 3.73B | 4.80B | 2.11B | 2.67B |
Investing Cash Flow | -1.51B | -626.15M | -740.66M | -1.45B | -1.73B |
Financing Cash Flow | -1.82B | -1.67B | -1.03B | -706.72M | -671.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥24.32B | 7.33 | 3.09% | 11.73% | 51.77% | ||
79 Outperform | ¥19.41B | 9.78 | 4.80% | 6.94% | 13.25% | ||
77 Outperform | ¥15.96B | 7.79 | 4.27% | 5.82% | -11.79% | ||
75 Outperform | ¥33.13B | 14.87 | 3.38% | 7.79% | 47.38% | ||
73 Outperform | ¥93.27B | 24.31 | 2.49% | 5.02% | -21.81% | ||
63 Neutral | $34.61B | 5.36 | -11.67% | 1.95% | 5.33% | -20.62% | |
55 Neutral | ¥24.15B | ― | 2.77% | 3.49% | -241.96% |